<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23505" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pathology, Inflammation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stone</surname>
            <given-names>William L.</given-names>
          </name>
          <aff>East Tennessee State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Burns</surname>
            <given-names>Bracken</given-names>
          </name>
          <aff>East Tennessee State University (ETSU)</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>William Stone declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bracken Burns declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23505.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Inflammation is an ancient medical term initially referring to classic signs and symptoms, including edema, erythema (redness), warmness, pain, and loss of function (stiffness and immobility).<xref ref-type="bibr" rid="article-23505.r1">[1]</xref>&#x000a0;Currently, inflammation&#x000a0;is recognized as a set of changing responses to tissue injury primarily caused by&#x000a0;factors such as toxic chemicals, environmental agents, trauma, overuse, or infection. Some of these responses can facilitate&#x000a0;wound healing and infection control or pathology, as in many chronic disease states.<xref ref-type="bibr" rid="article-23505.r2">[2]</xref> Inflammation is a second-line defense against infectious agents. The responses evoked by inflammation are a keystone of pathology. Diseases where inflammation plays a dominant pathological role have the suffix <italic toggle="yes">-itis</italic>.&#x000a0;Both cell-mediated and humoral responses of the immune system are central to inflammation.<xref ref-type="bibr" rid="article-23505.r3">[3]</xref> This activity summarizes&#x000a0;how inflammation is linked to cardiovascular disease and cancer, two global causes of mortality and morbidity.</p>
      </sec>
      <sec id="article-23505.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Acute or Chronic Inflammation</bold>
</p>
        <p>Acute inflammation has a rapid onset&#x000a0;of minutes or hours, typically resolves within a few days, has classic signs and symptoms, and has a cellular infiltrate primarily consisting of neutrophils.<xref ref-type="bibr" rid="article-23505.r4">[4]</xref> The erythema observed in acute inflammation results from increased blood flow to the affected area due to vasodilation.&#x000a0;Vasodilation is triggered by various mediators, with histamine&#x000a0;as a notable example, acting on vascular smooth muscle. This process initially affects the arterioles and opens new capillary beds in the affected area.<xref ref-type="bibr" rid="article-23505.r5">[5]</xref>&#x000a0;Besides blood vessels, lymphatic vessels&#x000a0;are active in acute inflammation.&#x000a0;In inflammation, lymph flow is increased and helps drain edema fluid that accumulates because of increased vascular permeability. Along with fluid, leukocytes, cell debris, and microbes may also enter the lymph.<xref ref-type="bibr" rid="article-23505.r6">[6]</xref>&#x000a0;Similar to blood vessels, lymphatic vessels proliferate during inflammatory reactions to handle the increased load.<xref ref-type="bibr" rid="article-23505.r7">[7]</xref></p>
        <p>The acute inflammatory process is a 4-stage process that begins with the initiation&#x000a0;phase, triggered by the injury. This phase involves changes to the microcirculation, leading to fluid loss and the migration of white blood cells to the injured area. The amplification&#x000a0;phase follows, where chemical substances direct additional types of white blood cells to the site, enhancing the response. The rapid neutralization of the injury and debris removal characterizes the destruction phase. Finally, the termination&#x000a0;phase requires the action of chemical substances to halt or regulate the inflammatory process, preventing excessive damage if unchecked.<xref ref-type="bibr" rid="article-23505.r2">[2]</xref></p>
        <p>Cryotherapy is an effective treatment for acute inflammation caused by musculoskeletal injury, leading to decreased pain and more rapid<bold>&#x000a0;</bold>return to participation.<bold>&#x000a0;</bold><xref ref-type="bibr" rid="article-23505.r8">[8]</xref>&#x000a0;The primary mechanism is reduced sensory nerve transmission at the site, whereas peripheral vasoconstriction slows the metabolic rate. Reducing oxidative stress reduces secondary ischemic injury and alleviates inflammation.<xref ref-type="bibr" rid="article-23505.r9">[9]</xref> Cryotherapy is most effective when applied soon after the injury, within 24 to 48 hours.<xref ref-type="bibr" rid="article-23505.r10">[10]</xref><bold>&#x000a0;</bold>Chronic inflammation has a slow onset of days, a long duration of years, less prominent classical signs and symptoms, and cellular infiltrate composed of monocytes, macrophages, and lymphocytes.<xref ref-type="bibr" rid="article-23505.r11">[11]</xref>&#x000a0;Chronic inflammation can arise from persistent infections caused by microorganisms that are difficult to eliminate, such as mycobacteria, viruses, fungi, and parasites, triggering delayed-type hypersensitivity reactions that may lead to granulomatous responses or unresolved acute inflammation evolving into a chronic state.<xref ref-type="bibr" rid="article-23505.r12">[12]</xref></p>
        <p>Prolonged exposure to toxic agents, whether exogenous, such as particulate silica causing silicosis, or endogenous, such as excessive cholesterol and lipids contributing to atherosclerosis, can also induce chronic inflammation.<xref ref-type="bibr" rid="article-23505.r13">[13]</xref>&#x000a0;In addition, chronic inflammation occurs in diseases not typically viewed as inflammatory disorders, including neurodegenerative diseases&#x000a0;such as Alzheimer disease, metabolic syndrome, type 2 diabetes, and certain cancers, where inflammatory processes promote tumor development.<xref ref-type="bibr" rid="article-23505.r14">[14]</xref><xref ref-type="bibr" rid="article-23505.r15">[15]</xref></p>
        <p>
<bold>Mediators and Biomarkers of Inflammation</bold>
</p>
        <p>The discovery of cellular and molecular inflammatory mediators and the development of sensitive biomarkers have rapidly advanced our understanding of inflammation and&#x000a0;its role in pathology.&#x000a0;</p>
        <p>Key biomarkers include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Reactive oxygen species (ROS) and reactive nitrogen oxide species (RNOS)</p>
          </list-item>
          <list-item>
            <p>Formation of DNA adducts</p>
          </list-item>
          <list-item>
            <p>Cytokines, such as interleukin-6<italic toggle="yes">&#x000a0;</italic>(IL-6) and tumor necrosis factor-alpha, and chemokines</p>
          </list-item>
          <list-item>
            <p>Acute-phase proteins, such as C-reactive protein or CRP</p>
          </list-item>
          <list-item>
            <p>Prostaglandins</p>
          </list-item>
          <list-item>
            <p>Cyclooxygenase (COX)-related metabolites</p>
          </list-item>
          <list-item>
            <p>Inflammation-related growth factors and transcription factors, such as NF-kappaB</p>
          </list-item>
          <list-item>
            <p>Major immune cell types</p>
          </list-item>
        </list>
        <p>The specific immune cells and mediators at play are variable and dependent upon the injury, the onset or duration of the injury, and multiple genetic loci. CRP is a widely used clinical inflammatory biomarker that presents in&#x000a0;2 forms with distinct functions&#x02014;a homopentamer termed native CRP and a monomer.&#x000a0;Two clinical assays are available for CRP&#x02014;a standard assay and a high-sensitivity assay (hs-CRP).<xref ref-type="bibr" rid="article-23505.r1">[1]</xref><xref ref-type="bibr" rid="article-23505.r16">[16]</xref><xref ref-type="bibr" rid="article-23505.r17">[17]</xref><xref ref-type="bibr" rid="article-23505.r18">[18]</xref><xref ref-type="bibr" rid="article-23505.r19">[19]</xref> &#x000a0;</p>
        <p>
<bold>Inflammation and Cardiovascular Disease</bold>
</p>
        <p>Hs-CRP is often used to evaluate increased cardiovascular disease risk.&#x000a0;Increased levels of plasma hs-CRP are a&#x000a0;cardiovascular risk factor, in addition to low-density lipoprotein&#x000a0;cholesterol and the degree of metabolic syndrome. Some suggest that increased inflammation from any cause, such as periodontal disease and arthritis, damages vascular endothelium. Central obesity, a risk factor for type 2 diabetes and cardiovascular disease,&#x000a0;is also associated with increased hs-CRP in metabolic syndrome. However, it remains uncertain whether CRP plays an active role in causing heart disease or if lowering hs-CRP is a valid goal for preventing heart disease.<xref ref-type="bibr" rid="article-23505.r20">[20]</xref><xref ref-type="bibr" rid="article-23505.r21">[21]</xref>&#x000a0;</p>
        <p>In contrast, the 2018 CANTOS trial on tertiary prevention in patients with a history of myocardial infarction demonstrated that reducing hs-CRP levels&#x000a0;with&#x000a0;canakinumab effectively decreased major&#x000a0;cardiovascular events&#x000a0;by 25%. This effect was primarily observed in patients whose treatment lowered hs-CRP levels to less than 2 mg/mL. Canakinumab is a monoclonal antibody that targets interleukin-1-&#x003b2; and does not affect plasma lipoprotein levels. Most participants in the CANTOS trial were already on statin therapy.<xref ref-type="bibr" rid="article-23505.r22">[22]</xref>&#x000a0;Statins, besides lowering low-density lipoprotein cholesterol, also lower hs-CRP. Nevertheless, a large-scale study found that simvastatin's effectiveness in lowering a first major vascular event was unaffected by baseline CRP levels.<xref ref-type="bibr" rid="article-23505.r23">[23]</xref></p>
        <p>Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic, antipyretic, antiplatelet, and anti-inflammatory effects.<xref ref-type="bibr" rid="article-23505.r24">[24]</xref>&#x000a0;These drugs are among the world's most used or prescribed medications. The effects of NSAIDs on CRP levels are mixed and depend upon the particular NSAID.<xref ref-type="bibr" rid="article-23505.r25">[25]</xref>&#x000a0;In patients taking NSAIDs for rheumatoid arthritis, naproxen was associated with a decreased CRP, whereas lumiracoxib was associated with an increased CRP.<xref ref-type="bibr" rid="article-23505.r26">[26]</xref>&#x000a0;Lumiracoxib is a selective inhibitor of COX-2, the inducible form of COX, whereas&#x000a0;naproxen is a nonselective COX inhibitor, inhibiting COX-2 and COX-1, the constitutively expressed form of COX. The COX-2 selective inhibitors are collectively called coxibs. The more selective an NSAID is for COX-2, the greater&#x000a0;the&#x000a0;effect on increasing CRP. Due to the increased risk of severe&#x000a0;cardiovascular events, celecoxib is the only coxib available in the&#x000a0;American market.<xref ref-type="bibr" rid="article-23505.r27">[27]</xref>&#x000a0;The&#x000a0;cardiovascular risks posed by NSAIDs are an area of active research and are&#x000a0;an under-recognized issue.</p>
        <p>
<bold>Inflammation, Aging, and Cancer</bold>
</p>
        <p>Inflammation is closely associated with an increased production of ROS and RNOS, which can damage DNA. Chronic inflammation is a process that can increase mutations and cancer risk. Increased cellular or tumor microenvironmental ROS production&#x000a0;is associated with diminished control of cell growth. For example, activated macrophages are a major source of ROS, and these inflammatory cells are located in the tumor microenvironment of breast cancer tumors, promoting growth and metastasis. Chronic inflammation is associated with many types of&#x000a0;cancer and all stages of cancer.<xref ref-type="bibr" rid="article-23505.r28">[28]</xref></p>
        <p>Obesity, which increases chronic inflammation, is now recognized as a major and preventable increased cancer risk factor. Increasing evidence supports a strong positive association between CRP levels and cancer. For example, elevated CRP levels at the time of diagnosis are associated with breast cancer,&#x000a0;its subtypes, and poor outcomes.<xref ref-type="bibr" rid="article-23505.r29">[29]</xref>&#x000a0;Elevated levels of CRP are all positively associated with the risk of epithelial cancers, such as liver, lung, colorectal, endometrial, breast, and ovarian cancer. CRP levels&#x000a0;are a valuable prognostic biomarker in various adult tumors. Elevated CRP&#x000a0;levels are linked with a shorter survival time for most solid tumors.<xref ref-type="bibr" rid="article-23505.r30">[30]</xref>&#x000a0;Aging is a major risk factor for cancer, and systemic, sterile (non-infection-caused), age-related chronic inflammation&#x02014;termed inflamm-aging or inflammaging&#x02014;is an underlying etiological connection.<xref ref-type="bibr" rid="article-23505.r31">[31]</xref>&#x000a0;CRP and other inflammatory biomarkers increase with age. Gut microbiota&#x000a0;is more pro-inflammatory with aging and contributes to systemic chronic inflammation.<xref ref-type="bibr" rid="article-23505.r32">[32]</xref></p>
        <p>
<bold>Diet, Exercise, and Inflammation Levels </bold>
</p>
        <p>Over the last decade, a relatively consistent understanding of the relationship between lifestyle and inflammation has emerged. Individuals with high CRP levels of greater than 3.0 mg/L tend to be physically inactive, have higher plasma glucose levels, are less likely to follow the Mediterranean diet, have a higher incidence of hypertension, have a lower HDL-cholesterol (anti-atherogenic), and increased abdominal obesity. Adopting a Mediterranean diet combined with a medium physical activity markedly reduces the incidence of high CRP by 72%.&#x000a0;The dietary inflammatory index is a flexible tool for accessing the relationship between diet and inflammation,&#x000a0; with smartphone apps available for easy access.<xref ref-type="bibr" rid="article-23505.r33">[33]</xref></p>
      </sec>
      <sec id="article-23505.s3" sec-type="Clinical Pathology">
        <title>Clinical Pathology</title>
        <p>Specimen collection and processing&#x000a0;are crucial for avoiding common preanalytical errors and ensuring accurate test results. Confirming the patient's identity is the most important step in phlebotomy, ensuring that the collected specimen is from the correct patient and is matched to the correct test request form. For hs-CRP testing, serum is typically the preferred specimen type. However, other acceptable options include lithium, heparin plasma, K2-EDTA plasma, and whole blood, especially capillary whole blood obtained through a fingertip prick.&#x000a0;The median cubital vein in the antecubital fossa is the preferred site for collecting venous blood in adults because the vein is large and is close to the skin's surface.<xref ref-type="bibr" rid="article-23505.r34">[34]</xref><xref ref-type="bibr" rid="article-23505.r35">[35]</xref><xref ref-type="bibr" rid="article-23505.r34">[34]</xref><xref ref-type="bibr" rid="article-23505.r36">[36]</xref>&#x000a0;&#x000a0;</p>
        <p>Particle-enhanced turbidimetry and nephelometry are&#x000a0;2 common techniques used for hs-CRP quantitative determination in clinical laboratory settings. Both methods rely on the principle of light scattering by antigen-antibody complexes but differ slightly in the geometry of light detection.&#x000a0;In both techniques, monoclonal or polyclonal antibodies specific to hs-CRP are immobilized (adsorbed) onto the surface of latex particles. These particles are typically made of polystyrene and have a uniform size. When a sample containing hs-CRP is introduced, the antigen (hs-CRP) binds to the specific antibodies on the latex particles, forming antigen-antibody complexes.<xref ref-type="bibr" rid="article-23505.r37">[37]</xref><xref ref-type="bibr" rid="article-23505.r38">[38]</xref></p>
        <p>Turbidity measures the total amount of light scattered by a solution at an angle of 180&#x000b0; from the incident light source, similar to the absorbance measurements in a spectrophotometer.&#x000a0;The key concern of turbidimetric measurements is a signal-to-noise ratio, which is critical for accurate measurements at low concentrations.&#x000a0;The nephelometer measures&#x000a0;the light scattered by the antigen-antibody complexes at a right angle (90&#x000b0;) to the incident light source. This specific angle provides a stronger signal for the antigen-antibody complexes compared to the background light scattering from the solution.&#x000a0;Using latex particles with immobilized antibodies enhances the sensitivity of the measurement, especially at low hs-CRP concentrations, which is important for assessing low-grade inflammation. These techniques are readily automated and can be integrated into clinical chemistry analyzers, allowing for high-throughput analysis of hs-CRP levels.<xref ref-type="bibr" rid="article-23505.r39">[39]</xref><xref ref-type="bibr" rid="article-23505.r40">[40]</xref><xref ref-type="bibr" rid="article-23505.r41">[41]</xref></p>
      </sec>
      <sec id="article-23505.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The signs of inflammation include loss of function, heat, pain, redness, and swelling. Inflammation is part of the body's biological response to harmful stimuli, such as irritants, pathogens, and damaged cells. Differentiating inflammation and infection is clinically&#x000a0;relevant due to many pathologies that&#x000a0;distinguish evaluation&#x000a0;and treatment.</p>
      </sec>
      <sec id="article-23505.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23505&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23505">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23505/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23505">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23505.s6">
        <title>References</title>
        <ref id="article-23505.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Punchard</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Whelan</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Adcock</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The Journal of Inflammation.</article-title>
            <source>J Inflamm (Lond)</source>
            <year>2004</year>
            <month>Sep</month>
            <day>27</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">15813979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zuo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory responses and inflammation-associated diseases in organs.</article-title>
            <source>Oncotarget</source>
            <year>2018</year>
            <month>Jan</month>
            <day>23</day>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>7204</fpage>
            <page-range>7204-7218</page-range>
            <pub-id pub-id-type="pmid">29467962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nathan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nonresolving inflammation.</article-title>
            <source>Cell</source>
            <year>2010</year>
            <month>Mar</month>
            <day>19</day>
            <volume>140</volume>
            <issue>6</issue>
            <fpage>871</fpage>
            <page-range>871-82</page-range>
            <pub-id pub-id-type="pmid">20303877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hannoodee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nasuruddin</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Inflammatory Response</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>6</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">32310543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdulkhaleq</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Assi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zamri-Saad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taufiq-Yap</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hezmee</surname>
                <given-names>MNM</given-names>
              </name>
            </person-group>
            <article-title>The crucial roles of inflammatory mediators in inflammation: A review.</article-title>
            <source>Vet World</source>
            <year>2018</year>
            <month>May</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>627</fpage>
            <page-range>627-635</page-range>
            <pub-id pub-id-type="pmid">29915501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwager</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Detmar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Inflammation and Lymphatic Function.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>308</fpage>
            <pub-id pub-id-type="pmid">30863410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zgraggen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ochsenbein</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Detmar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An important role of blood and lymphatic vessels in inflammation and allergy.</article-title>
            <source>J Allergy (Cairo)</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>672381</fpage>
            <pub-id pub-id-type="pmid">23431319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hubbard</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Aronson</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Denegar</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Does Cryotherapy Hasten Return to Participation? A Systematic Review.</article-title>
            <source>J Athl Train</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-94</page-range>
            <pub-id pub-id-type="pmid">15085216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vieira Ramos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pinheiro</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Messa</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Delfino</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Marqueti</surname>
                <given-names>Rde C</given-names>
              </name>
              <name>
                <surname>Salvini</surname>
                <given-names>Tde F</given-names>
              </name>
              <name>
                <surname>Durigan</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Cryotherapy Reduces Inflammatory Response Without Altering Muscle Regeneration Process and Extracellular Matrix Remodeling of Rat Muscle.</article-title>
            <source>Sci Rep</source>
            <year>2016</year>
            <month>Jan</month>
            <day>04</day>
            <volume>6</volume>
            <fpage>18525</fpage>
            <pub-id pub-id-type="pmid">26725948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Castro-Nu&#x000f1;ez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Troncoso-Cibrian</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Carrillo-Varguez</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez S&#x000e1;nchez</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Sarmiento</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lanzagorta-Rebollo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Neelakantan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effect of cryotherapy duration on experimentally induced connective tissue inflammation <italic>in vivo</italic>.</article-title>
            <source>Restor Dent Endod</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>e29</fpage>
            <pub-id pub-id-type="pmid">37675446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pahwa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jialal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <chapter-title>Chronic Inflammation</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">29630225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Campisi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Verdin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carrera-Bastos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Targ</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferrucci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gilroy</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Fasano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weyand</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goronzy</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rando</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Effros</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kleinstreuer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Slavich</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Chronic inflammation in the etiology of disease across the life span.</article-title>
            <source>Nat Med</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>1822</fpage>
            <page-range>1822-1832</page-range>
            <pub-id pub-id-type="pmid">31806905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parke</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Parke</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Chemical-induced inflammation and inflammatory diseases.</article-title>
            <source>Int J Occup Med Environ Health</source>
            <year>1996</year>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-7</page-range>
            <pub-id pub-id-type="pmid">8972163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baby</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rajguru</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Thakkannavar</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Pujari</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>Inflammation and cancer.</article-title>
            <source>Ann Afr Med</source>
            <year>2019</year>
            <season>Jul-Sep</season>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>121</fpage>
            <page-range>121-126</page-range>
            <pub-id pub-id-type="pmid">31417011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allavena</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garlanda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borrello</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sica</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pathways connecting inflammation and cancer.</article-title>
            <source>Curr Opin Genet Dev</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-10</page-range>
            <pub-id pub-id-type="pmid">18325755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Scherer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Muir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schildkraut</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spitz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Le Marchand</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Ulrich</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>A review of the application of inflammatory biomarkers in epidemiologic cancer research.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>1729</fpage>
            <page-range>1729-51</page-range>
            <pub-id pub-id-type="pmid">24962838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heap</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>van Heel</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>The genetics of chronic inflammatory diseases.</article-title>
            <source>Hum Mol Genet</source>
            <year>2009</year>
            <month>Apr</month>
            <day>15</day>
            <volume>18</volume>
            <issue>R1</issue>
            <fpage>R101</fpage>
            <page-range>R101-6</page-range>
            <pub-id pub-id-type="pmid">19297396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sproston</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Ashworth</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Role of C-Reactive Protein at Sites of Inflammation and Infection.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>754</fpage>
            <pub-id pub-id-type="pmid">29706967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fritzer-Szekeres</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Szekeres</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gehrig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gy&#x000f6;ngy&#x000f6;si</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bergler-Klein</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Comparison of High-Sensitivity C-Reactive Protein vs C-reactive Protein for Cardiovascular Risk Prediction in Chronic Cardiac Disease.</article-title>
            <source>J Appl Lab Med</source>
            <year>2022</year>
            <month>Oct</month>
            <day>29</day>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>1259</fpage>
            <page-range>1259-1271</page-range>
            <pub-id pub-id-type="pmid">36136302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ridker</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>C-reactive protein, inflammation, and cardiovascular disease: clinical update.</article-title>
            <source>Tex Heart Inst J</source>
            <year>2005</year>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>384</fpage>
            <page-range>384-6</page-range>
            <pub-id pub-id-type="pmid">16392225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>den Engelsen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koekkoek</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Gorter</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>van den Donk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salom&#x000e9;</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Rutten</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis.</article-title>
            <source>Cardiovasc Diabetol</source>
            <year>2012</year>
            <month>Mar</month>
            <day>14</day>
            <volume>11</volume>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">22417460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ridker</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>MacFadyen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Everett</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Libby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thuren</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glynn</surname>
                <given-names>RJ</given-names>
              </name>
              <collab>CANTOS Trial Group</collab>
            </person-group>
            <article-title>Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Jan</month>
            <day>27</day>
            <volume>391</volume>
            <issue>10118</issue>
            <fpage>319</fpage>
            <page-range>319-328</page-range>
            <pub-id pub-id-type="pmid">29146124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Heart Protection Study Collaborative Group</collab>
              <name>
                <surname>Jonathan Emberson</surname>
              </name>
              <name>
                <surname>Derrick Bennett</surname>
              </name>
              <name>
                <surname>Emma Link</surname>
              </name>
              <name>
                <surname>Sarah Parish</surname>
              </name>
              <name>
                <surname>John Danesh</surname>
              </name>
              <name>
                <surname>Jane Armitage</surname>
              </name>
              <name>
                <surname>Rory Collins</surname>
              </name>
            </person-group>
            <article-title>C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study.</article-title>
            <source>Lancet</source>
            <year>2011</year>
            <month>Feb</month>
            <day>05</day>
            <volume>377</volume>
            <issue>9764</issue>
            <fpage>469</fpage>
            <page-range>469-76</page-range>
            <pub-id pub-id-type="pmid">21277016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panchal</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Prince Sabina</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities.</article-title>
            <source>Food Chem Toxicol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>172</volume>
            <fpage>113598</fpage>
            <pub-id pub-id-type="pmid">36608735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bindu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mazumder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bandyopadhyay</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.</article-title>
            <source>Biochem Pharmacol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>180</volume>
            <fpage>114147</fpage>
            <pub-id pub-id-type="pmid">32653589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Bliddal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Furst</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Boers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Danneskiold-Sams&#x000f8;e</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials.</article-title>
            <source>Arthritis Rheum</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>64</volume>
            <issue>11</issue>
            <fpage>3511</fpage>
            <page-range>3511-21</page-range>
            <pub-id pub-id-type="pmid">22833186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zarghi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arfaei</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.</article-title>
            <source>Iran J Pharm Res</source>
            <year>2011</year>
            <season>Fall</season>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>655</fpage>
            <page-range>655-83</page-range>
            <pub-id pub-id-type="pmid">24250402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantovani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The inflammation - cancer connection.</article-title>
            <source>FEBS J</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>285</volume>
            <issue>4</issue>
            <fpage>638</fpage>
            <page-range>638-640</page-range>
            <pub-id pub-id-type="pmid">29479848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Rubal</surname>
              </name>
              <name>
                <surname>Banipal</surname>
                <given-names>RPS</given-names>
              </name>
              <name>
                <surname>Vashistha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dhiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Munshi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcome.</article-title>
            <source>Curr Probl Cancer</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-129</page-range>
            <pub-id pub-id-type="pmid">29921457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavares</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia.</article-title>
            <source>Porto Biomed J</source>
            <year>2021</year>
            <season>Jan-Feb</season>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>e123</fpage>
            <pub-id pub-id-type="pmid">33884319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonardi</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Accardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Monastero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nicoletti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Libra</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ageing: from inflammation to cancer.</article-title>
            <source>Immun Ageing</source>
            <year>2018</year>
            <volume>15</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">29387133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagpal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mainali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ahmadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kavanagh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kitzman</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kushugulova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marotta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Gut microbiome and aging: Physiological and mechanistic insights.</article-title>
            <source>Nutr Healthy Aging</source>
            <year>2018</year>
            <month>Jun</month>
            <day>15</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>267</fpage>
            <page-range>267-285</page-range>
            <pub-id pub-id-type="pmid">29951588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pitsavos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panagiotakos</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Tzima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lentzas</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chrysohoou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>UN</given-names>
              </name>
              <name>
                <surname>Stefanadis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Diet, exercise, and C-reactive protein levels in people with abdominal obesity: the ATTICA epidemiological study.</article-title>
            <source>Angiology</source>
            <year>2007</year>
            <season>Apr-May</season>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-33</page-range>
            <pub-id pub-id-type="pmid">17495273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hawkins</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Managing the pre- and post-analytical phases of the total testing process.</article-title>
            <source>Ann Lab Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-16</page-range>
            <pub-id pub-id-type="pmid">22259773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brindle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shofer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research.</article-title>
            <source>J Immunol Methods</source>
            <year>2010</year>
            <month>Oct</month>
            <day>31</day>
            <volume>362</volume>
            <issue>1-2</issue>
            <fpage>112</fpage>
            <page-range>112-20</page-range>
            <pub-id pub-id-type="pmid">20850446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuhira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kasashima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Urai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakatani</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Safety of Venipuncture Sites at the Cubital Fossa as Assessed by Ultrasonography.</article-title>
            <source>J Patient Saf</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-105</page-range>
            <pub-id pub-id-type="pmid">29140886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dominici</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Luraschi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Franzini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Measurement of C-reactive protein: two high sensitivity methods compared.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2004</year>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>280</fpage>
            <page-range>280-4</page-range>
            <pub-id pub-id-type="pmid">15356879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Sedrick</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moulton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rifai</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications.</article-title>
            <source>Clin Chem</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-8</page-range>
            <pub-id pub-id-type="pmid">10759469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thuillier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Demarquilly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Szymanowicz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boniface</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Braidy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Daunizeau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gascht</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gruson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lagabrielle</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lasnier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lemdani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macchi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Poulin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Sainte Hermine</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sancho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schellenberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sevin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vaubourdolle</surname>
                <given-names>M</given-names>
              </name>
              <collab>CNBH (Coll&#x000e8;ge national de biochimie des h&#x000f4;pitaux)</collab>
            </person-group>
            <article-title>[Nephelometry or turbidimetry for the determination of albumin, ApoA, CRP, haptoglobin, IgM and transthyretin: which choice?].</article-title>
            <source>Ann Biol Clin (Paris)</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-78</page-range>
            <pub-id pub-id-type="pmid">18227006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omar</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Matjafri</surname>
                <given-names>MZ</given-names>
              </name>
            </person-group>
            <article-title>Turbidimeter design and analysis: a review on optical fiber sensors for the measurement of water turbidity.</article-title>
            <source>Sensors (Basel)</source>
            <year>2009</year>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>8311</fpage>
            <page-range>8311-35</page-range>
            <pub-id pub-id-type="pmid">22408507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23505.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banait</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wanjari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danade</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Banait</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>e30225</fpage>
            <pub-id pub-id-type="pmid">36381804</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
